Company Performance Metrics
Kerato develops bioengineered corneal tissue products for medical, commercial and research applications. The company focuses on addressing donor cornea shortages by using tissue engineering and biomaterials to produce corneas in the laboratory and cell-free hydrogels for corneal repair. Its LiQD Cornea product is an injectable, biomimetic hydrogel
designed to repair corneal trauma and perforations by promoting natural tissue regeneration. Kerato also develops an ocular toxicity testing platform that replicates biosynthetic human-corneal stroma in vitro. This platform enables pharmaceutical and cosmetics companies to evaluate ocular toxicity without using animal testing by providing bioequivalent tissue models. Through these offerings, Kerato serves clinicians, researchers and corporate R&D teams involved in ophthalmic healthcare and safety testing.
